Tonix Pharmaceuticals Holding Corp.
TNXP
$37.99
$2.145.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -21.09% | -2.04% | 29.94% | 183.05% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.09% | -2.04% | 29.94% | 183.05% | -- |
| Cost of Revenue | -28.82% | 10.11% | 63.78% | 276.96% | -- |
| Gross Profit | 6.99% | -22.24% | -23.06% | 45.02% | -- |
| SG&A Expenses | 33.52% | 11.52% | 15.40% | 15.90% | 24.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.33% | -28.94% | -30.37% | -26.52% | -14.04% |
| Operating Income | 13.45% | 31.54% | 34.33% | 33.27% | 23.99% |
| Income Before Tax | 45.36% | -33.81% | -11.47% | -11.76% | -22.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 45.36% | -33.81% | -11.47% | -11.76% | -22.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.36% | -33.81% | -11.47% | -11.76% | -22.12% |
| EBIT | 13.45% | 31.54% | 34.33% | 33.27% | 23.99% |
| EBITDA | 11.21% | 31.90% | 35.27% | 34.94% | 26.18% |
| EPS Basic | 99.15% | 27.96% | -14.19% | -- | -- |
| Normalized Basic EPS | 96.17% | 3.23% | -- | -- | -- |
| EPS Diluted | 99.15% | 27.96% | -14.19% | -- | -- |
| Normalized Diluted EPS | 96.17% | 3.23% | -- | -- | -- |
| Average Basic Shares Outstanding | 23,324.09% | 31,630.82% | -- | -- | -- |
| Average Diluted Shares Outstanding | 19,727.03% | 21,813.12% | 23,528.80% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |